Home › Plasmablastic Lymphoma › Illinois
Plasmablastic Lymphoma clinical trials in Illinois
3 studies for Plasmablastic Lymphoma are looking for participants at sites in Illinois.
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- University of Illinois at Chicago, Chicago
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT04139304HEME-25 Open-Label Feasibility Study of Elranatamab Utilized as Consolidation in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
- University of Illinois at Chicago, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07647432Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
- Memorial Hospital East, Shiloh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07332507From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.